Life Sciences Update | 2022 October

Vancouver

Market Summary

Public & Private Funding (2022)

Fast Lab Stats

Fast Lab Stats 12.9K

• British Columbia is home to more than 300 life sciences companies, including biopharmaceutical and medical device companies. • Vancouver’s life sciences industry is underpinned by a highly skilled workforce, prime location and high quality of life. • The new St. Paul’s Hospital development in the core market of Mt. Pleasant has spurred significant interest in the surrounding neighborhood from some of the most notable life sciences companies in the country, including AbCellera, Zymeworks, Aurina Pharmaceutical and STEMCELL technologies. • Vancouver is home to some of the country’s top medical facilities. Vancouver General Hospital (VGH) is the country’s third largest hospital and Western Canada’s most specialized hospital with over 40% of patients coming from outside of Vancouver. Additionally, VGH is one of Canada’s most renowned teaching hospitals through its affiliation with the University of British Columbia (UBC). • The Vancouver life sciences industry is further strengthened by government incentives and infrastructure inclusive of grants and tax incentives, along with the BC Cancer Agency, BC Centre for Excellence in HIV/AIDS, AdMare, TRIUMF Vancouver Coastal Research Institute, Michael Smith Laboratories, Genome BC and the BC Knowledge Development Fund.

Company

Deal Type

Completed

Type

$ Raised (MM)

Vesalius Cardiovascular

Early Stage VC

Jan 2022

VC

$5.0

Total Life Sciences Employment 87.9% Life Sciences Employment 10-Year Growth Rate

ABOzymes Biomedical

Seed Round

Mar 2022

VC

$2.1

Andira Pharmaceuticals

Seed Round

Mar 2022

VC

$1.6

Hemptown USA

Later Stage VC

Jan 2022

VC

$0.6

VCENNA

Angel (individual)

Jan 2022

VC

$0.3

Hemptown USA

Later Stage VC

Apr 2022

VC

$0.1

HTuO

Early Stage VC

Jan 2022

VC

$0.03

Nirvana Life Sciences (CNQ: NIRV)

IPO

Mar 2022

IPO

PharmAla Biotech (CNQ: MDMA)

IPO

Jan 2022

IPO

Life Sciences Labor: Average Monthly Job Postings

Representative Life Sciences Companies

Company

Type

0 100 200 300 400 500 600 700 800 900

Stemcell Technologies

HQ, Lab

AbCellera

HQ, Lab

Zymeworks

HQ

Medipure Pharmaceuticals Inc

HQ

HQ

Symvivo Inc

Chinook Therapeutics

HQ

HQ

Anandia Laboratories Inc

2018

2019

2020 2021

2022

Amgen

Research Facility

Hologic Regional

R&D Center

Annual Life Sciences Degree Completions 2010 1,283

Bio Degree-Awarding Institutions, Metro Area

Top NIH-Funded Institutions (2018-2022)

•

British Columbia Institute of Technology

$21M University of British Columbia $4M Provincial Health Services Authority $1M British Columbia Cancer Agency

• •

Camosum College

Langara College (Health Science Program) Simon Fraser University University of British Columbia (School of Biomedical Engineering, Biological Sciences Centre)

2019 1,588 Up 24%

• •

Research Contributors

Svetlana Lebedeva svetlana.lebedeva@ca.cushwake.com

•

University of Victoria

Kyle Grundy kyle.grundy@ca.cushwake.com

Sources: Cushman & Wakefield Research, CoStar, National Institutes of Health (NIH), Lightcast, Pitchbook

34

/ CUSHMAN & WAKEFIELD

LIFE SCIENCES UPDATE | 2022 OCTOBER